Your browser doesn't support javascript.
loading
Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study.
Rosenthal, Mark; Clement, Paul M; Campone, Mario; Gil-Gil, Miguel J; DeGroot, John; Chinot, Olivier; Idbaih, Ahmed; Gan, Hui; Raizer, Jeffrey; Wen, Patrick Yung; Pineda, Estela; Donnet, Valerie; Mills, David; El-Hashimy, Mona; Mason, Warren.
Afiliação
  • Rosenthal M; Medical Oncology, Royal Melbourne Hospital, Melbourne, Victoria, Australia mark.rosenthal@petermac.org.
  • Clement PM; Department of Oncology, Leuven Cancer Institute, Leuven, Belgium.
  • Campone M; Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint Herblain, Pays de la Loire, France.
  • Gil-Gil MJ; Institut Català d'Oncologia, Barcelona, Spain.
  • DeGroot J; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chinot O; Department of Neuro-Oncology, Assistance Publique - Hôpitaux de Marseille Office Central des Bibliothèques, Marseille, Provence-Alpes-Côte d'Azur, France.
  • Idbaih A; Department of Neuro-Oncology, Sorbonne Université, Paris, Île-de-France, France.
  • Gan H; Oncology, Olivia Newton-John Cancer & Wellness Centre, Heidelberg, Victoria, Australia.
  • Raizer J; Department of Neuro-Oncology, Northwestern Medical Faculty Foundation, Chicago, Illinois, USA.
  • Wen PY; Department of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Pineda E; Medical Oncology, University of Barcelona Faculty of Medicine and Health Sciences, Barcelona, Catalunya, Spain.
  • Donnet V; Novartis Pharma SAS, Paris, France.
  • Mills D; Novartis Pharma, Basel, Basel-Stadt, Switzerland.
  • El-Hashimy M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Mason W; Department of Oncology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
ESMO Open ; 5(4)2020 07.
Article em En | MEDLINE | ID: mdl-32665311

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: ESMO Open Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: ESMO Open Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália